Medically reviewed by a licensed healthcare professional. Last updated April 2026.

The Price Problem

Tirzepatide is the most effective weight loss medication ever studied. The SURMOUNT-1 trial showed 20.9% average body weight loss at the 15mg dose. But at $1,060+ per month retail, most people cannot afford it at sticker price.

Key Takeaways
  • Brand-name tirzepatide (Mounjaro/Zepbound) retails for $1,000-1,200/month
  • Eli Lilly's savings card drops it to ~$499/month for uninsured, or $25/month with commercial insurance
  • Compounded tirzepatide from telehealth providers starts around $149-400/month
  • Costco and LillyDirect sometimes offer lower retail prices than chain pharmacies

The good news: almost nobody actually pays retail. Between manufacturer programs, compounding pharmacies, and telehealth providers, there are multiple paths to affordable tirzepatide. Here is every option, ranked from cheapest to most expensive.

Price Comparison Table

Option Monthly Cost Medication Type Insurance Needed?
Lilly Savings Card (insured) $25/mo Brand-name Yes (commercial)
Compounded tirzepatide (telehealth) $149-400/mo Compounded No
LillyDirect $299-449/mo Brand-name No
Lilly Savings Card (uninsured) ~$499/mo Brand-name No
Costco retail $900-1,000/mo Brand-name No
Chain pharmacy retail $1,000-1,200/mo Brand-name No

Option 1: Lilly Savings Card ($25/month with insurance)

If you have commercial health insurance that covers tirzepatide, Eli Lilly's savings card brings your copay down to as low as $25 per 28-day supply. This is the cheapest way to get brand-name tirzepatide, period.

How to get it:

  • Visit the Zepbound or Mounjaro savings page on lilly.com
  • Complete the registration form
  • Present the digital card at your pharmacy along with your insurance card

Who qualifies:

  • Must have commercial (private) health insurance
  • Must have a valid prescription
  • Must be a US resident age 18+

Who does not qualify:

  • Medicare, Medicaid, or TRICARE beneficiaries
  • Patients with government-funded insurance
  • Patients whose insurance excludes the savings card through a copay accumulator program

Important note: Some insurance plans use copay accumulator programs, which means the savings card payment does not count toward your deductible or out-of-pocket maximum. Ask your pharmacist if your plan does this.

Option 2: Compounded Tirzepatide ($149-400/month)

Compounded tirzepatide from 503A and 503B pharmacies offers the most affordable path for patients without insurance coverage. Multiple telehealth providers now offer compounded tirzepatide programs that include the medication, provider consultations, and ongoing monitoring. The cheapest verified all-in options come from Henry Meds and GobyMeds at roughly $149–$199/month, followed by Ro, Hims, Strut Health, and Eden in the $199–$299 band. Higher-touch programs from Found, Embody, and Yucca Health sit closer to $300–$400 but bundle more provider time and labs. Marketplace options such as Sesame, PlushCare, and Lemonaid let you pay per visit rather than a monthly subscription. Newer entrants including Willow, Form Health, TrimRx, and Fridays have rolled out compounded tirzepatide tracks at competitive price points. If you want medication plus behavioral coaching bundled together, Calibrate, Noom, and WeightWatchers each offer program-style wrappers with prescribing access.

What is compounded tirzepatide?

Compounding pharmacies create custom preparations of tirzepatide. These are not generic medications. They are pharmacy-prepared versions that are not FDA-approved but contain the same active ingredient. The FDA allows compounding under certain regulations when patients need access to medications that may be in shortage or when a commercially available product does not meet a patient's specific needs.

Price range by provider:

Prices vary significantly depending on the telehealth company, dosage, and whether the program includes additional services like nutritional coaching or lab work. Most programs fall in the $200-400/month range, with some introductory offers starting lower.

Things to check before choosing a compounding provider:

  • Is the pharmacy 503A or 503B licensed?
  • Does the provider include medical consultations in the price?
  • What happens if you need a dose adjustment?
  • Are there cancellation fees?

Take our provider quiz to find the best option for your budget and preferences.

Option 3: LillyDirect ($299-449/month)

Eli Lilly launched LillyDirect as a self-pay option for patients who want brand-name tirzepatide without insurance. You order directly through Lilly's platform and the medication ships to your home.

This is a relatively new program and pricing has shifted since launch. It is worth checking the current LillyDirect pricing, as Lilly has been adjusting rates to compete with compounding pharmacies.

Option 4: Lilly Savings Card Without Insurance (~$499/month)

If you do not have insurance that covers tirzepatide, Lilly's savings card still offers a discount, though it is less dramatic than the insured version. Commercially insured patients whose plan does not cover tirzepatide typically pay around $499 per month, which is roughly half the retail price.

This is significantly more than compounded tirzepatide but gives you the FDA-approved, brand-name product manufactured by Eli Lilly.

Option 5: Costco Pharmacy

Costco consistently offers some of the lowest retail prices for prescription medications. You do not need a Costco membership to use their pharmacy in most states. Tirzepatide at Costco typically runs $900-1,000/month, which is $100-200 less than chain pharmacies.

Worth checking if you are paying retail and want the brand-name product. Use GoodRx or similar tools to compare Costco pricing against your local options.

Insurance Coverage: Mounjaro vs. Zepbound

Here is a tactical consideration: Mounjaro and Zepbound contain the exact same medication (tirzepatide) but have different FDA-approved indications.

  • Mounjaro is approved for type 2 diabetes
  • Zepbound is approved for weight loss

Insurance companies are far more likely to cover Mounjaro for diabetes than Zepbound for weight loss. If you have type 2 diabetes or prediabetes in addition to needing weight management, getting a Mounjaro prescription may be the easier path to insurance coverage.

Talk to your provider about which indication is most appropriate for your situation. See our insurance coverage guide for insurer-specific details.

The Bottom Line

Nobody should pay full retail for tirzepatide. If you have commercial insurance, the Lilly savings card at $25/month is unbeatable. If you are uninsured or your insurance does not cover it, compounded tirzepatide at $149-400/month from a reputable telehealth provider is the most affordable option. LillyDirect and the uninsured savings card offer middle-ground pricing for patients who want the brand-name product.

Use our cost guide for a full breakdown of all GLP-1 medication pricing, or compare telehealth providers to find the best compounded tirzepatide program for your needs.

💡Pro Tip

Always compare GLP-1 providers by total monthly cost at your maintenance dose, not the advertised starting price. Factor in consultation fees, required lab work, and shipping charges. Month-to-month plans give you flexibility to switch if better options emerge.

How Tirzepatide Compares to Other GLP-1 Options

Tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes) targets both GLP-1 and GIP receptors, which is why it tends to produce more weight loss than semaglutide-only medications. In the SURMOUNT-1 trial, tirzepatide produced up to 22.5% body weight loss at the highest dose, compared to 14.9% for semaglutide (Wegovy/Ozempic) in STEP 1.

If tirzepatide is still too expensive, semaglutide alternatives include compounded semaglutide (from $99 per month), brand-name Wegovy through NovoCare ($349 per month self-pay), or the new Wegovy oral pill ($149 per month at starter doses). Non-GLP-1 options like Contrave and Xenical are cheaper but produce less weight loss. The newest oral GLP-1, Foundayo (orforglipron), launched in April 2026 at $149 per month.

Sources

  1. Eli Lilly Zepbound Savings Program
  2. SURMOUNT-1 Clinical Trial Results, NEJM 2022
  3. FDA Compounding Policy

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.